
Synthetic Communications p. 151 - 164 (2006)
Update date:2022-08-17
Topics:
Bhuniya, Debnath
Gujjary, Srinivas
Sengupta, Sujata
Triphenylphosphine-catalyzed Michael addition of oximes 2 onto Baylis-Hillman (B-H) adducts 1 led to an easy access to a novel class of oxime functionalized aldol products 3. This demonstrates the first use of an oxygen-centered nucleophile in Michael addition to B-H adducts, without touching any other functional group. Deprotection of oxime in 3 was further demonstrated using molecular hydrogen (1 atm) and 10% Pd/C (cat.) to furnish functionalized 1,3-diols 4 as potentially useful synthons with optional backbone choice (R 3 and EWG). Copyright Taylor & Francis LLC.
View More
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY
Contact:0086-0757-85609331
Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd
Contact:86-27-52341789
Address:Room 1518 B suite, optical valley time square, No 111 Guanshan Road, Hongshan District,Wuhan,Hubei Province,China.
Shanghai Yuanye Bio-Technology Co., Ltd.
website:http://www.shyuanye.com
Contact:+86-21-61845781
Address:Building 6, No. 465, Changta Road,Songjiang District,Shanghai,China
Doi:10.1039/d0ra03884a
(2020)Doi:10.1016/S0022-328X(00)90481-9
(1972)Doi:10.1016/S0957-4166(00)82246-6
(1993)Doi:10.1016/j.mencom.2020.05.016
(2020)Doi:10.1055/s-1997-717
(1997)Doi:10.1016/0006-3002(59)90118-0
(1959)